Drug intelligence / Profile preview

chondroitin sulfate

Development stage
Phase 4
Lead developer
Bioiberica
Administration
Oral
01

Overview

Chondroitin sulfate is a natural biomacromolecule belonging to the class of glycosaminoglycans, which are unbranched complex polysaccharides. It is a major component of the extracellular matrix (ECM), where it constitutes an essential component of proteoglycans. Chondroitin sulfate is available as both a pharmaceutical-grade drug and a dietary supplement. It is primarily used for the treatment of osteoarthritis, where it is considered a symptomatic slow-acting drug (SYSADOA) due to its anti-inflammatory activity, its ability to stimulate the synthesis of proteoglycans and hyaluronic acid, and its role in decreasing the catabolic activity of chondrocytes. It has also shown serendipitous clinical and histopathological improvement in patients with psoriasis.

Brand names
StructumCondroflexCondrosulfCondrosan
Other names
CSChondroitin Sulphate硫酸软骨素
02

Targets

PTN (Pleiotrophin)

Beyond the preview

Go deeper on chondroitin sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chondroitin sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call